8 March 2023

READ MOREAkston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

23 January 2023

READ MOREAkston Biosciences Strengthens Board with Addition of John T. Preston

1 November 2022

READ MOREAkston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial

9 August 2022

READ MOREAkston Biosciences Receives U.S. Patent for Once-A-Week Human Insulin

9 February 2021

READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

12 April 2021

READ MOREAkston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine

9 February 2021

READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

5 January 2021

READ MOREAkston and LakePharma Announce Strategic Partnership to Manufacture AKS-452

22 July 2020

READ MOREAkston Biosciences Receives $2.5M Milestone Payment

27 May 2020

READ MOREAkston Biosciences Awarded NIDDK Phase IIb Grant